Telmisartan Attenuates the Growth of Epithelium-like Cells and Glomerular Injury in Spontaneously Hypertensive Rats

Curr Med Sci. 2021 Jun;41(3):498-504. doi: 10.1007/s11596-021-2368-4. Epub 2021 Jun 15.

Abstract

The abnormal growth of epithelium-like cells has been noticed in spontaneously hypertensive rats (SHRs) with hypertensive nephropathy. However, the characteristics of abnormal epithelium-like cells and their pathogenesis in hypertensive nephropathy are not fully understood. In the present study, we investigated the correlation of epithelium-like cells with glomerular injury, and the effects of early drug intervention with telmisartan, an anti-hypertensive drug, on the growth of epithelium-like cells. The results showed that the epithelium-like cells were obviously observed lining along the luminal surface of Bowman's capsule in glomeruli, significantly resulting in the atrophy of the glomerular tuft. Some of the epithelium-like cells strongly expressed proliferating cell nuclear antigen (PCNA) and vimentin, indicating active cellular proliferation. The incidence of epithelium-like cells varied from 13.6% to 54.4% of glomeruli in 48-week-old SHRs, and from 5.1% to 18.0% of glomeruli in age-matched Wistar-Kyoto (WKY) rats (P<0.01). The linear regression analysis further confirmed an obvious correlation between the incidence of epithelium-like cells and the glomerular injury. Moreover, early intervention with telmisartan could dramatically attenuate the progression of epithelium-like cells growth. However, no significant effect of telmisartan on the established epithelium-like cells was observed. Taken together, we demonstrated the involvement of abnormal epithelium-like cells growth in glomerular injury during hypertensive nephropathy in SHRs, and firstly showed the positive effects of the anti-hypertensive drug on the progression of epithelium-like cells growth.

Keywords: epithelium-like cell; glomerular injury; hypertension; spontaneously hypertensive rats (SHRs); telmisartan.

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology*
  • Blood Pressure / drug effects
  • Disease Models, Animal
  • Epithelium / drug effects
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / genetics
  • Hypertension / pathology
  • Hypertension, Renal / drug therapy*
  • Hypertension, Renal / genetics
  • Hypertension, Renal / pathology
  • Kidney / drug effects
  • Kidney / pathology
  • Nephritis / drug therapy*
  • Nephritis / genetics
  • Nephritis / pathology
  • Rats
  • Rats, Inbred SHR
  • Telmisartan / pharmacology*

Substances

  • Antihypertensive Agents
  • Telmisartan

Supplementary concepts

  • Hypertensive Nephropathy